×
About 3,590 results

ALLMedicine™ Eosinophilic Esophagitis Center

Research & Reviews  1,203 results

Cytosponge Protocol IRB 11-006429
https://clinicaltrials.gov/ct2/show/NCT01585103

May 18th, 2022 - This study is being done to collect data on the potential use of the cytosponge as non-invasive tool in evaluating patients with eosinophilic esophagitis.

Natural History and Genetics of Food Allergy and Related Conditions
https://clinicaltrials.gov/ct2/show/NCT02504853

May 13th, 2022 - There are approximately 15 million Americans, including 6 million children, who have a potentially life-threatening food allergy. The prevalence of this disease has increased over the last three decades, in both the United States and other develop...

Current and emerging therapies for eosinophilic esophagitis.
https://doi.org/10.2500/aap.2022.43.220014
Allergy and Asthma Proceedings; Sher ER, Ross JA et. al.

May 8th, 2022 - Background: Eosinophilic esophagitis (EoE) is a Type-2 chronic inflammatory food antigen-driven disease of the esophagus, characterized by eosinophilic predominant inflammation and a constellation of symptoms. The incidence and prevalence of EoE h...

Eosinophilic esophagitis: from discovery to effective treatment.
https://doi.org/10.2500/aap.2022.43.220025
Allergy and Asthma Proceedings; Bellanti JA, Settipane RA

May 8th, 2022 - Eosinophilic esophagitis: from discovery to effective treatment.|2022|Bellanti JA,Settipane RA,|diagnosis,drug therapy,

A chromosomal duplication encompassing IL-33 causes a novel Hyper IgE phenotype charact...
https://doi.org/10.1053/j.gastro.2022.04.026
Gastroenterology Marwaha AK, Laxer R et. al.

May 1st, 2022 - A chromosomal duplication encompassing IL-33 causes a novel Hyper IgE phenotype characterized by eosinophilic esophagitis and generalized autoimmunity.|2022|Marwaha AK,Laxer R,Liang M,Muise AM,Eiwegger T,|

see more →

Guidelines  7 results

Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA I...
https://doi.org/10.1053/j.gastro.2020.02.039
Gastroenterology Rank MA, Sharaf RN et. al.

May 4th, 2020 - Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute ...

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinic...
https://doi.org/10.1053/j.gastro.2020.02.038
Gastroenterology Hirano I, Chan ES et. al.

May 4th, 2020 - AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|standards,organization & administration,stand...

AGA institute and the joint task force on allergy-immunology practice parameters clinic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135034
Annals of Allergy, Asthma & Immunology : Official Publica... Hirano I, Chan ES et. al.

Apr 28th, 2020 - AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|therapeutic use,diagnosis,drug therapy,therap...

Treatment of Eosinophilic Esophagitis (EoE): Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.03.070
Gastroenterology

Apr 10th, 2020 - Treatment of Eosinophilic Esophagitis (EoE): Clinical Decision Support Tool.|2020| ,|

Spotlight: Treatment of Eosinophilic Esophagitis (EoE).
https://doi.org/10.1053/j.gastro.2020.03.069
Gastroenterology Hirano I, Sharaf R et. al.

Apr 10th, 2020 - Spotlight: Treatment of Eosinophilic Esophagitis (EoE).|2020|Hirano I,Sharaf R,Stollman N,Wang K,Falck-Ytter Y,|standards,organization & administration,standards,methods,standards,diagnosis,immunology,therapy,methods,standards,complications,diagno...

see more →

Clinicaltrials.gov  64 results

Cytosponge Protocol IRB 11-006429
https://clinicaltrials.gov/ct2/show/NCT01585103

May 18th, 2022 - This study is being done to collect data on the potential use of the cytosponge as non-invasive tool in evaluating patients with eosinophilic esophagitis.

Natural History and Genetics of Food Allergy and Related Conditions
https://clinicaltrials.gov/ct2/show/NCT02504853

May 13th, 2022 - There are approximately 15 million Americans, including 6 million children, who have a potentially life-threatening food allergy. The prevalence of this disease has increased over the last three decades, in both the United States and other develop...

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
https://clinicaltrials.gov/ct2/show/NCT03633617

Apr 28th, 2022 - The primary objectives of the study by study part are: Part A: To determine the treatment effect of dupilumab compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as assessed by histological and clinical meas...

Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial
https://clinicaltrials.gov/ct2/show/NCT05083312

Apr 13th, 2022 - This is a randomized, double-blind, placebo-controlled study of APT-1011, followed by an open-label extension (OLE) in adolescents (≥12 to <18 years) with EoE that will evaluate the efficacy and safety of APT-1011 3 mg administered HS for the indu...

Antihistamines in Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT04248712

Apr 6th, 2022 - The purpose of this research is to determine if antihistamines are safe and effective for the treatment of eosinophilic esophagitis. Antihistamines are frequently used for the treatment of gastroesophageal reflux disease and allergic disorders, an...

see more →

News  155 results

FDA Approves First Drug for Eosinophilic Esophagitis
https://www.medscape.com/viewarticle/974374

May 20th, 2022 - The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent, Regeneron) to treat eosinophilic esophagitis (EoE) in adults and children aged 12 years and older weighing at least 40 kg. EoE is a chronic inflammatory disorder driven by...

Psychiatric Illness Associated With Eosinophilic Esophagitis
https://www.medscape.com/viewarticle/972274

Apr 18th, 2022 - People with eosinophilic esophagitis (EoE) may run an increased risk of mood disorders, anxiety, and attention-deficit/hyperactivity disorder (ADHD) and should be screened for those conditions, researchers say. "It's important to know that there i...

Topical Steroid Shows Promise for Eosinophilic Esophagitis
https://www.medscape.com/viewarticle/970311

Mar 15th, 2022 - A topical formulation of fluticasone designed to dissolve and coat the esophagus appears safe and effective for the treatment of eosinophilic esophagitis (EOE), according to new results from a phase 2b study. The results pave the way for phase 3 c...

EoE: Budesonide oral suspension still shows promise
https://www.mdedge.com/internalmedicine/article/251328/gastroenterology/eoe-budesonide-oral-suspension-still-shows-promise
Brandon May

Feb 1st, 2022 - Results from a double-blind, phase 3 trial suggest budesonide oral suspension may improve eosinophilic esophagitis (EoE) outcomes, providing promise for meeting the ongoing unmet treatment needs for individuals with the disease. In December 2020,.

FDA OKs First-in-Class Biologic for Severe Asthma
https://www.medpagetoday.com/allergyimmunology/asthma/96288

Dec 20th, 2021 - The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenanc...

see more →

Patient Education  7 results see all →